U S PHYSICAL THERAPY INC /NV Comprehensive Income
U S PHYSICAL THERAPY INC /NV (USPH) reported Comprehensive Income of $9.97 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:ComprehensiveIncomeNetOfTax · last filed 2026-08-07
- U S PHYSICAL THERAPY INC /NV comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2026-06-30 was $9.97M, a 15.53% decline year-over-year.
- U S PHYSICAL THERAPY INC /NV comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2026-03-31 was $5.30M, a 40.48% decline year-over-year.
- U S PHYSICAL THERAPY INC /NV comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-12-31 was $3.92M, a 63.37% decline year-over-year.
- U S PHYSICAL THERAPY INC /NV comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-09-30 was $12.87M, a 231.44% increase year-over-year.
- U S PHYSICAL THERAPY INC /NV comprehensive income (loss), net of tax, attributable to parent for fiscal 2025 was $37.50M, a 19.26% increase from fiscal 2024.
- U S PHYSICAL THERAPY INC /NV comprehensive income (loss), net of tax, attributable to parent for fiscal 2024 was $31.44M, a 16.37% increase from fiscal 2023.
- U S PHYSICAL THERAPY INC /NV comprehensive income (loss), net of tax, attributable to parent for fiscal 2023 was $27.02M, a 25.29% decline from fiscal 2022.
- U S PHYSICAL THERAPY INC /NV comprehensive income (loss), net of tax, attributable to parent for fiscal 2022 was $36.16M, a 11.43% decline from fiscal 2021.
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month |
|---|---|---|---|---|
| 2026-06-30 | $9.97M 10-Q · filed 2026-08-07 | $15.27M 10-Q · filed 2026-08-07 | $19.19M derived: sum of 3 quarters · filed 2026-08-07 | $32.06M derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | $5.30M 10-Q · filed 2026-05-08 | $9.22M derived: sum of 2 quarters · filed 2026-05-08 | $22.09M derived: sum of 3 quarters · filed 2026-05-08 | $33.89M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | $3.92M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $16.79M derived: sum of 2 quarters · filed 2026-02-27 | $28.59M derived: sum of 3 quarters · filed 2026-08-07 | $37.50M 10-K · filed 2026-02-27 |
| 2025-09-30 | $12.87M 10-Q · filed 2025-11-07 | $24.67M derived: sum of 2 quarters · filed 2026-08-07 | $33.58M 10-Q · filed 2025-11-07 | $44.28M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | $11.80M 10-Q · filed 2026-08-07 | $20.71M 10-Q · filed 2026-08-07 | $31.41M derived: sum of 3 quarters · filed 2026-08-07 | $35.29M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | $8.91M 10-Q · filed 2026-05-08 | $19.61M derived: sum of 2 quarters · filed 2026-05-08 | $23.49M derived: sum of 3 quarters · filed 2026-05-08 | $30.98M derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $10.70M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $14.59M derived: sum of 2 quarters · filed 2026-02-27 | $22.07M derived: sum of 3 quarters · filed 2026-02-27 | $31.44M 10-K · filed 2026-02-27 |
| 2024-09-30 | $3.88M 10-Q · filed 2025-11-07 | $11.37M derived: sum of 2 quarters · filed 2025-11-07 | $20.74M 10-Q · filed 2025-11-07 | $18.43M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-06-30 | $7.48M 10-Q · filed 2025-08-08 | $16.86M 10-Q · filed 2025-08-08 | $14.55M derived: sum of 3 quarters · filed 2026-02-27 | $24.75M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-03-31 | $9.37M 10-Q · filed 2025-05-09 | $7.06M derived: sum of 2 quarters · filed 2026-02-27 | $17.27M derived: sum of 3 quarters · filed 2026-02-27 | $30.33M derived: sum of 4 quarters · filed 2026-02-27 |
| 2023-12-31 | -$2.31M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $7.90M derived: sum of 2 quarters · filed 2026-02-27 | $20.96M derived: sum of 3 quarters · filed 2026-02-27 | $27.02M 10-K · filed 2026-02-27 |
| 2023-09-30 | $10.20M 10-Q · filed 2024-11-08 | $23.27M derived: sum of 2 quarters · filed 2024-11-08 | $29.32M 10-Q · filed 2024-11-08 | $31.51M derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-06-30 | $13.06M 10-Q · filed 2024-08-14 | $19.12M 10-Q · filed 2024-08-14 | $21.31M derived: sum of 3 quarters · filed 2025-03-03 | $35.68M derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-03-31 | $6.06M 10-Q · filed 2024-05-08 | $8.24M derived: sum of 2 quarters · filed 2025-03-03 | $22.62M derived: sum of 3 quarters · filed 2025-03-03 | $33.42M derived: sum of 4 quarters · filed 2025-03-03 |
| 2022-12-31 | $2.19M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $16.56M derived: sum of 2 quarters · filed 2025-03-03 | $27.36M derived: sum of 3 quarters · filed 2025-03-03 | $36.16M 10-K · filed 2025-03-03 |
| 2022-09-30 | $14.38M 10-Q · filed 2023-11-08 | $25.18M derived: sum of 2 quarters · filed 2023-11-08 | $33.98M 10-Q · filed 2023-11-08 | $44.19M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | $10.80M 10-Q · filed 2023-08-09 | $19.60M 10-Q · filed 2023-08-09 | $29.81M derived: sum of 3 quarters · filed 2024-02-29 | $39.82M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | $8.80M 10-Q · filed 2023-05-05 | $19.01M derived: sum of 2 quarters · filed 2024-02-29 | $29.02M derived: sum of 3 quarters · filed 2024-02-29 | $41.46M derived: sum of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | $10.21M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $20.22M derived: sum of 2 quarters · filed 2024-02-29 | $32.66M derived: sum of 3 quarters · filed 2024-02-29 | $40.83M 10-K · filed 2024-02-29 |
| 2021-09-30 | $10.01M 10-Q · filed 2022-11-08 | $22.45M derived: sum of 2 quarters · filed 2022-11-08 | $30.62M 10-Q · filed 2022-11-08 | |
| 2021-06-30 | $12.44M 10-Q · filed 2022-08-08 | $20.61M 10-Q · filed 2022-08-08 | ||
| 2020-12-31 | $35.19M 10-K · filed 2023-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |